Cite
MLA Citation
Anas Younes et al.. “Nivolumab for classical Hodgkin's lymphoma after failure of both autologous stem-cell transplantation and brentuximab vedotin: a multicentre, multicohort, single-arm phase 2 trial.” Lancet oncology, vol. 17, no. 9, n.d., pp. 1283–1294. http://access.bl.uk/ark:/81055/vdc_100036256411.0x00002f